Reference78 articles.
1. Sharma KK, Hales TG, Rao VJ, NicDaeid N, McKenzie C (2019) The search for the “next” euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning. Forensic Toxicol 37(1):1–16. https://doi.org/10.1007/s11419-018-0454-5
2. Varshneya NB, Hassanien SH, Holt MC, Stevens DL, Layle NK, Bassman JR, et al (2021) Respiratory depressant effects of fentanyl analogs. American Society for Pharmacology and Experimental Therapeutics Virtual Meeting
3. Baumann MH, Majumdar S, Le Rouzic V, Hunkele A, Uprety R, Huang XP et al (2018) Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace. Neuropharmacology 134:101–107. https://doi.org/10.1016/j.neuropharm.2017.08.016
4. Van Bever WF, Niemegeers CJ, Schellekens KH, Janssen PA (1976) N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety margin. Arzneimittelforschung 26(8):1548–1551
5. Armenian P, Vo KT, Barr-Walker J, Lynch KL (2018) Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology 134:121–132. https://doi.org/10.1016/j.neuropharm.2017.10.016
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献